Common drug switching during long-term antiresorptive treatment: experience of four osteoporosis centers in Poland (2001–2005)

MLA

Franek, Edward, et al. “Common Drug Switching during Long-Term Antiresorptive Treatment: Experience of Four Osteoporosis Centers in Poland (2001–2005).” Aging: Clinical and Experimental Research, vol. 20, no. 6, Dec. 2008, pp. 528–32. EBSCOhost, https://doi.org/10.1007/BF03324880.

APA

Franek, E., Talalaj, M., Wichrowska, H., Czerwienska, B., Filip, R., Safranow, K., Marcinowska-Suchowierska, E., & Wiecek, A. (2008). Common drug switching during long-term antiresorptive treatment: experience of four osteoporosis centers in Poland (2001–2005). Aging: Clinical and Experimental Research, 20(6), 528–532. https://doi.org/10.1007/BF03324880

Chicago

Franek, Edward, Marek Talalaj, Hanna Wichrowska, Beata Czerwienska, Rafal Filip, Krzysztof Safranow, Ewa Marcinowska-Suchowierska, and Andrzej Wiecek. 2008. “Common Drug Switching during Long-Term Antiresorptive Treatment: Experience of Four Osteoporosis Centers in Poland (2001–2005).” Aging: Clinical and Experimental Research 20 (6): 528–32. doi:10.1007/BF03324880.